|
|
| 2022, Vol. 31(9): 848-853 DOI: 10.3760/cma.j.cn113030-20210118-00029 | ||
| Active surveillance and response evaluation strategy after neoadjuvant therapy for esophageal cancer | ||
| Liu Yunsong1, Men Yu1,2, Hui Zhouguang1,2 | ||
| 1Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China; 2Department of VIP Medical Services, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China |
||
| Received 2021-01-18 Revised null | ||
| Supporting info | ||
| null | ||
|
